Opendata, web and dolomites

NIRT MONITOR SIGNED

ACCURATE EASY-TO-USE AND NON-INVASIVE DEVICE FOR EARLY DETECTION AND MONITORING OF HEART FAILURE IN REAL TIME

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NIRT MONITOR project word cloud

Explore the words cloud of the NIRT MONITOR project. It provides you a very rough idea of what is the project "NIRT MONITOR" about.

41    diagnosis    first    germany    standard    decrease    medicine    market    sales    diagnosing    15    disposables    uses    countries    business    patent    settings    leasing    ventricular    sucessful    monitor    filled    spain    time    performed    adopters    internal    er    38    later    share    commercialization    profit    30    revenues    heart    spent    direct    safety    procedure    complications    risky    catheter    billion    homecare    save    fees    diastolic    alternative    efficient       payment    100    roi    annually    feasibility    assay    pct    re    gp    invasive    quality    app    treatment    icu    offices    cardiology    left    france    patient    catheterization    medical    units    admissions    offers    prevention    indirect    80    accuracy    cloud    coralert    release    hf    estimate    reducing    commercial    nirt    sme    acute    pressure    expansion    complexes    lvedp    europeans    5m    measuring    11    life    safe    innovative    financial    healthcare    device    patients    clinical    asymp    million    physicians    hospitalizations    distributors    lab    gold    hospitals    model    inexpensive    solution    penetration    validated   

Project "NIRT MONITOR" data sheet

The following table provides information about the project.

Coordinator
CORALERT LTD 

Organization address
address: TCHELET 17
city: MISGAV
postcode: 2017400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://coralertmed.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CORALERT LTD IL (MISGAV) coordinator 50˙000.00

Map

 Project objective

Heart Failure (HF) affects 15 million of Europeans and €6.41 billion are annually spent on its management and treatment by the healthcare system, CORALERT aims to favour the HF prevention and decrease its costs through its innovative NIRT MONITOR medical device. Gold standard procedures for diagnosing HF using catheterization are risky and complexes. As validated by clinical assay, NIRT MONITOR offers an alternative, safe and easy to use method to early diagnosis HF in real time by non-invasive measuring of LVEDP (Left Ventricular End Diastolic Pressure) providing physicians and in- and out-patient settings an early diagnosis of HF and its complications. NIRT MONITOR will improve the quality of life of patients while reducing hospitalizations by 30% and re-admissions by 80%. Cardiology, ICU, ER and Internal Medicine Units from hospitals (€5.1 billion of European market), GP offices and homecare settings will be the target users. NIRT MONITOR business model will be based on devices sales/leasing for early adopters and later from indirect sales/leasing through medical technology distributors. Revenues will be also generated by direct and indirect sales of disposables and by Cloud App payment fees. NIRT MONITOR will be an inexpensive solution (€10,000/device) in comparison with one catheter lab procedure (first two uses will save the 100% of the costs of one use of the standard method). NIRT MONITOR´s safety, easy to use, cost-efficient and accuracy will ensure its penetration into targeted European countries (Spain, France and Germany) and expansion over other European countries and US. We estimate a profit of ≈€38.5M after four years of commercialization with a ROI of 11.8 and a market share of 4.5%. We have filled US and PCT patent applications. To ensure the sucessful release of NIRT MONITOR into the market, a feasibility study will be performed during SME Phase 1 to evaluate any technical, commercial and financial issues related to the project.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NIRT MONITOR" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NIRT MONITOR" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

ECOBIOMASS (2019)

Achieving unique wines through an efficient production process

Read More  

COUNTMITMENT (2019)

NATURAL CAPITAL ACCOUNTANCY TO IMPROVE REPORTING AND ENVIRONMENTAL PERFORMANCE

Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More